Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

MEN 2A syndrome – multiple endocrine neoplasia with autosomal dominant transmisson

Show simple item record

dc.contributor.author Șipitco, Natalia
dc.contributor.author Ungureanu, Sergiu
dc.contributor.author Alexa, Zinaida
dc.contributor.author Parnov, Mihail
dc.contributor.author Romanenco, Richarda
dc.contributor.author Balanici, Mihail
dc.date.accessioned 2020-11-10T08:27:34Z
dc.date.available 2020-11-10T08:27:34Z
dc.date.issued 2020-10
dc.identifier.uri https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii
dc.identifier.uri https://repository.usmf.md/handle/20.500.12710/12772
dc.description Surgery Department no 4, „Nicolae Testemitanu” State Medical and Pharmaceutical University, Endocrinology Department, Republican Clinical Hospital, Morphopathology Department, „Nicolae Testemitanu” SMPU, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare en_US
dc.description.abstract Introduction: Multiple endocrine neoplasias (MEN) are rare and complex autosomal dominant inherited syndromes caused by germline RET mutation and characterized by the association of tumors of two or more endocrine glands in the same patient. It occurs in 1:30000 individuals, and is reported in approximately 500–1000 families worldwide. Sipple syndrome (MEN2A) is characterized by the association of medullary thyroid carcinoma (MTC) (in 80-100% of cases), uni- or bilateral pheochromocytoma (in over 50% of cases) and primary hyperparathyroidism (15% to 30% of cases) in the same patient. The diagnosis can be confirmed by imaging methods and early lab tests (calcitonin, methanephrines). Genetic confirmation is mandatory when the Sipple syndrome is suspected. Laparoscopy is the choice of approach in surgical treatment. Case report: The patient, a 20-years old with MEN 2A syndrome, which has been manifested by bilateral pheochromocytoma and medullary thyroid carcinoma. It was a familial form, having first degree relatives (mother) with pheochromocytoma. Genetic testing was not performed due to the death of the first degree relatives. After a full check-up (imaging methods, lab tests) adrenal and thyroid gland tumors were detected. The patient underwent laparoscopic adrenalectomy on her left in 2015, on the right in 2019 and total thyroidectomy in 2020. Histopathological examination of the adrenal glands revealed multicentric alveolar pheochromocytoma, the thyroid tissue - non-encapsulated medullary carcinoma. The postoperative evolution is favorable. She is undergoing hormone replacement therapy. Recent tests (25.05.20): PTH - 19,3 pg/ml,TSH- 0,2ul/ml, ionic calcium – 1,09 mmol/l, calcitonin decreased from 121 to 18.7 pg/ml. Conclusions: The radical approach to MEN 2A syndrome is very important from both a therapeutic and surgical point of view. Imaging check-up in combination with annual monitoring of calcitonin, chromogranin A, and metanephrines in a patient with MEN 2A syndrome is a practical way to supervise the case and make timely decisions for surgical intervention and to prevent complications. If a pheochromocytoma is detected, adrenalectomy should be performed before thyroidectomy or other surgery to avoid intraoperative catecholamine release. Laparoscopy is the choice of approach in surgical treatment. Limitations only arise because Keywords of technical difficulties or tumor size. en_US
dc.language.iso en en_US
dc.publisher Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" en_US
dc.subject multiple endocrine neoplasia en_US
dc.subject Sipple syndrome en_US
dc.subject medullary thyroid carcinoma en_US
dc.title MEN 2A syndrome – multiple endocrine neoplasia with autosomal dominant transmisson en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics